Salt / ingredient
Metoprolol Succinate Extended Release 50mg + Telmisartan 40mg
For blood pressure and heart conditions + Lowers blood pressure
MRP data last verified: August 2026. Source: NPPA Pharma Sahi Daam, reproduced under the NPPA copyright policy.
Private-brand substitutes: kam se zyada
More about this medicine
Reference information
About Metoprolol Succinate Extended Release
This information is from US FDA labels, for reference only. Always follow your doctor's advice.
Common side effects
- tiredness
- dizziness
- depression
- shortness of breath
- bradycardia
- hypotension
- diarrhea
- pruritus
- rash
- well characterized in studies of telmisartan in hypertension
- only adverse events leading to discontinuation
- serious adverse events were recorded in subsequent studies of telmisartan for cardiovascular risk reduction
Safety advice
- Stop use and seek emergency help if you have signs of a severe allergic reaction.
- May cause low blood sugar. Watch for symptoms like shakiness, sweating, confusion.
- Consult your doctor before use if pregnant or breastfeeding.
- May affect the liver. Tell your doctor if you have liver problems.
- May affect the kidneys. Tell your doctor if you have kidney problems.
Uses
- etoprolol tartrate tablet is a beta-adrenergic blocker indicated for the treatment of: • Hypertension, to lower blood pressure.
- Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions.
- ( 1.1 ) • Angina Pectoris.
- ( 1.2 ) • Myocardial Infarction, to reduce the risk of cardiovascular mortality when used in conjunction with intravenous metoprolol therapy in patients with definite or suspected acute myocardial infarction in hemodynamically stable patients.
- ( 1.3 ) 1.1 Hypertension Metoprolol tartrate tablets are indicated for the treatment of hypertension in adult patients, to lower blood pressure.
How to take
- • Administer once daily with food or after a meal.
- Titrate at weekly or longer intervals as needed and tolerated.
- ( 2 ) • Hypertension: Recommended starting dosage is 100 mg daily, in single or divided doses.
- ( 2.1 ) • Angina Pectoris: Recommended starting dosage is 100 mg daily, given as two divided doses.
- ( 2.2 ) • Myocardial Infarction: The starting dosage depends upon tolerance of intravenous metoprolol, see full prescribing information.
Frequently Asked Questions about Metoprolol Succinate Extended Release 50mg + Telmisartan 40mg
What is the price of Metoprolol Succinate Extended Release 50mg + Telmisartan 40mg in India?
The price of Metoprolol Succinate Extended Release 50mg + Telmisartan 40mg in India depends on the manufacturer and channel. Official Government Jan Aushadhi generic rates start at ₹2.99 per unit.Private commercial brands vary from low-cost options to higher-priced branded formulations.
Is a Government Jan Aushadhi generic available for Metoprolol Succinate Extended Release 50mg + Telmisartan 40mg?
Metoprolol Succinate Extended Release 50mg + Telmisartan 40mg is listed under PMBI Jan Aushadhi (PMBI Code 1106) at ₹29.91 per pack.
How to find lower-cost substitutes for Metoprolol Succinate Extended Release 50mg + Telmisartan 40mg?
Search the active salt formulation (Metoprolol Succinate Extended Release 50mg + Telmisartan 40mg) on Sasta Parcha to view private-brand substitutes ranked strictly low-to-high by per-unit price. Always consult your prescribing doctor or pharmacist before changing medicine brands.